An association between human papillomavirus (HPV) infection and the development of
cervical cancer was initially suggested over 30 years ago, and today there is clear evidence …

The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection
causes> 550,000 cases of cervical and anogenital cancer worldwide annually. Infection also …

Introduction: The 9-valent human papillomavirus (9vHPV) vaccine covers the same HPV
types (6/11/16/18) as the quadrivalent HPV (qHPV) vaccine and 5 additional cancer-causing …

Human papillomaviruses (HPV) are a large group of viruses (more than 200 types identified)
that infect the epithelium of the skin and mucous membranes. The infections can be latent …

Background: the knowledge that sexually transmitted infection with one of a limited number
of human papillomaviruses (HPVs) is a central cause of almost all cervical cancers affords …

Human papillomavirus (HPV) related disease remains a major cause of morbidity and
mortality worldwide. Prophylactic vaccines have been recognized as the most effective …

Cervical and other cancers linked to the human papillomavirus (HPV) are a cause of
significant morbidity and mortality. Since the discovery of HPV as a cause of these cancers …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

Cervical cancer is one of the most common causes of cancer-related death in women. As a
result of several recent advances in molecular biology, the association between human …

Purpose. Human papillomavirus (HPV) disease and vaccines and several controversial
issues associated with vaccine administration are reviewed. Summary. HPV infection is the …